Nathaniel Slater, MD
Dermatology · Concord, NCNPI 1548647613
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 28.2% of the total. 2025 is the largest year on record at $1,536, more than ten times the $99 reported in 2020.
Across 152 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$848
- Johnson & Johnson$480
- UCB, Inc.$248
- Lilly USA, LLC$218
- Sanofi$177
- LEO Pharma Inc.$164
- plus $876 from 15 others
What the payments were for
- Food & beverage$2,71390%
- Education$29810%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $848 |
| Johnson & Johnson | 13 | $480 |
| UCB, Inc. | 16 | $248 |
| Lilly USA, LLC | 17 | $218 |
| Sanofi | 5 | $177 |
| LEO Pharma Inc. | 7 | $164 |
| Regeneron Healthcare Solutions, Inc. | 5 | $138 |
| E.r. Squibb & Sons, L.L.C. | 6 | $107 |
| Amgen | 4 | $100 |
| Arcutis Biotherapeutics, Inc. | 4 | $85 |
| Pfizer | 4 | $75 |
| Novartis | 3 | $69 |
| Sun Pharmaceutical Industries Inc. | 4 | $59 |
| Botanix SB Inc | 2 | $58 |
| Dermavant Sciences, Inc. | 2 | $44 |
| Journey Medical Corporation | 2 | $38 |
| Regeneron | 1 | $37 |
| Incyte Corporation | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Sandoz | 1 | $16 |
| Almirall LLC | 1 | $11 |
How this compares
$3,011 in reported general payments places this provider in the 55th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $81,914 |
| Clobetasol Propionate | 46 | $1,865 |
| Fluorouracil | 13 | $1,069 |
| Ketoconazole | 46 | $1,055 |
| Ciclopirox | 15 | $461 |
| Triamcinolone Acetonide | 48 | $373 |
| Hydrocortisone | 25 | $156 |
| Mupirocin | 13 | $138 |
| MethotrexateMethotrexate Sodium | 14 | $67 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Concord
- William HooverConcord$594K
- Heather HolahanConcord$46K
- Dhwani MehtaConcord$21K
- Lacey WallsConcord$13K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.